Inogen Inc. | Cash Flow

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
25,435.00
6,826.00
11,585.00
20,519.00
21,002.00
51,845
Depreciation, Depletion & Amortization
8,544.00
12,080.00
14,012.00
13,558.00
12,302.00
11,295
Other Funds
809.00
2,054.00
940.00
-
-
34,081
Funds from Operations
23,500.00
35,384.00
53,082.00
65,329.00
71,133.00
85,626
Changes in Working Capital
10,033.00
19,687.00
14,921.00
34,295.00
10,639.00
25,649
Net Operating Cash Flow
13,467.00
15,697.00
38,161.00
31,034.00
60,494.00
59,977
Capital Expenditures
18,142.00
16,237.00
12,489.00
8,016.00
10,227.00
Sale of Fixed Assets & Businesses
-
-
-
388.00
183.00
Purchase/Sale of Investments
-
-
16,816.00
4,299.00
9,892.00
Net Investing Cash Flow
18,142.00
16,254.00
29,305.00
11,927.00
24,430.00
Issuance/Reduction of Debt, Net
2,000.00
10,074.00
299.00
315.00
-
Net Financing Cash Flow
3,084.00
43,872.00
381.00
7,714.00
14,004.00
Net Change in Cash
1,591.00
43,315.00
9,270.00
26,745.00
50,102.00
Free Cash Flow
4,638.00
335.00
25,717.00
23,131.00
53,583.00
Deferred Taxes & Investment Tax Credit
21,798.00
1,564.00
4,760.00
1,036.00
7,947.00
11,595
Net Assets from Acquisitions
-
-
-
-
4,494.00
Change in Capital Stock
1,893.00
51,892.00
1,620.00
8,029.00
14,004.00
Exchange Rate Effect
-
-
33.00
76.00
34.00
Other Uses
-
17.00
-
-
-

About Inogen

View Profile
Address
326 Bollay Drive
Goleta California 93117
United States
Employees -
Website http://www.inogen.net
Updated 07/08/2019
Inogen, Inc . engages in the development, manufacture, and marketing of portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its products consists of Inogen One G4 system, Inogen One G3 system, Inogen One G2 system, and Inogen at Home.